270 related articles for article (PubMed ID: 22518283)
1. Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney.
Pinheiro SV; Simões E Silva AC
Int J Hypertens; 2012; 2012():414128. PubMed ID: 22518283
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
Santos RA; Ferreira AJ; Verano-Braga T; Bader M
J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
[TBL] [Abstract][Full Text] [Related]
3. New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis.
Ferreira AJ; Murça TM; Fraga-Silva RA; Castro CH; Raizada MK; Santos RA
Int J Hypertens; 2012; 2012():147825. PubMed ID: 22319643
[TBL] [Abstract][Full Text] [Related]
4. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
5. The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases.
Li XC; Zhang J; Zhuo JL
Pharmacol Res; 2017 Nov; 125(Pt A):21-38. PubMed ID: 28619367
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.
Santos RA; Ferreira AJ; Simões E Silva AC
Exp Physiol; 2008 May; 93(5):519-27. PubMed ID: 18310257
[TBL] [Abstract][Full Text] [Related]
7. ACE2: a new target for cardiovascular disease therapeutics.
Raizada MK; Ferreira AJ
J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
[TBL] [Abstract][Full Text] [Related]
8. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Červenka L; Bíbová J; Husková Z; Vaňourková Z; Kramer HJ; Herget J; Jíchová Š; Sadowski J; Hampl V
Physiol Res; 2015; 64(1):11-24. PubMed ID: 25194129
[TBL] [Abstract][Full Text] [Related]
9. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
[TBL] [Abstract][Full Text] [Related]
10. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
11. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
12. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
Lubel JS; Herath CB; Burrell LM; Angus PW
J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
[TBL] [Abstract][Full Text] [Related]
13. The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).
Santos RAS; Sampaio WO; Alzamora AC; Motta-Santos D; Alenina N; Bader M; Campagnole-Santos MJ
Physiol Rev; 2018 Jan; 98(1):505-553. PubMed ID: 29351514
[TBL] [Abstract][Full Text] [Related]
14. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
15. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis.
Iwai M; Horiuchi M
Hypertens Res; 2009 Jul; 32(7):533-6. PubMed ID: 19461648
[TBL] [Abstract][Full Text] [Related]
16. ACE2: more of Ang-(1-7) or less Ang II?
Ferrario CM
Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):1-6. PubMed ID: 21045683
[TBL] [Abstract][Full Text] [Related]
17. Opportunities for targeting the angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor pathway in hypertension.
Fraga-Silva RA; Ferreira AJ; Dos Santos RA
Curr Hypertens Rep; 2013 Feb; 15(1):31-8. PubMed ID: 23212695
[TBL] [Abstract][Full Text] [Related]
18. ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.
Xu P; Sriramula S; Lazartigues E
Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R804-17. PubMed ID: 21178125
[TBL] [Abstract][Full Text] [Related]
19. Update on the Angiotensin converting enzyme 2-Angiotensin (1-7)-MAS receptor axis: fetal programing, sex differences, and intracellular pathways.
Chappell MC; Marshall AC; Alzayadneh EM; Shaltout HA; Diz DI
Front Endocrinol (Lausanne); 2014 Jan; 4():201. PubMed ID: 24409169
[TBL] [Abstract][Full Text] [Related]
20. ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke.
Jiang T; Gao L; Lu J; Zhang YD
Curr Neuropharmacol; 2013 Mar; 11(2):209-17. PubMed ID: 23997755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
